Related references
Note: Only part of the references are listed.Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization
Sebastian Huss et al.
HISTOPATHOLOGY (2012)
Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST)
Marc Daniels et al.
CANCER LETTERS (2011)
Molecular analysis of WT1 and KIT mutations in patients from an Indian population with de novo acute myeloid leukemia: determination of incidence, distribution patterns, and report of a novel KIT mutation
Firoz Ahmad et al.
LEUKEMIA & LYMPHOMA (2011)
Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia
Sang Hyuk Park et al.
LEUKEMIA RESEARCH (2011)
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
Katherine A. Janeway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2010)
Pitfall in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
Sabine Merkelbach-Bruse et al.
BMC MEDICAL GENETICS (2010)
qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL
Jana Fassunke et al.
BMC MOLECULAR BIOLOGY (2010)
Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects
Gerhard J. Molderings et al.
IMMUNOGENETICS (2010)
Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
Christine Bodemer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657
Bianca F. Goemans et al.
LEUKEMIA RESEARCH (2010)
Rapid Detection of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia Using High-Resolution Melting Analysis
Oscar Fuster et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome
Jana Markova et al.
LEUKEMIA & LYMPHOMA (2009)
Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1
Chiara Mussi et al.
CLINICAL CANCER RESEARCH (2008)
Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours
J. Lasota et al.
HISTOPATHOLOGY (2008)
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
Michael C. Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene
H-U Schildhaus et al.
JOURNAL OF PATHOLOGY (2008)
Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset
Fanny Lanternier et al.
PLOS ONE (2008)
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
Chi Tarn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples
L-Y Shih et al.
LEUKEMIA (2008)
Mutation analysis of gastrointestinal stromal tumors:: increasing significance for risk assessment and effective targeted therapy
Eva Wardelmann et al.
VIRCHOWS ARCHIV (2007)
Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors
Jerzy Lasota et al.
LABORATORY INVESTIGATION (2007)
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21):: A Cancer and Leukemia Group B study
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Markku Miettinen et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2006)
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
Maria Debiec-Rychter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Gastrointestinal stromal tumors of the jejunum and ileum - A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology
J Lasota et al.
LABORATORY INVESTIGATION (2006)
Gastrointestinal stromal tumors in patients with neurofibromatosis 1 - A clinicopothologic and molecular genetic study of 45 cases
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Genetic testing in pheochromocytoma or functional paraganglioma
L Amar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gastrointestinal stromal tumors of the stomach in children and young adults - A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
BF Goemans et al.
LEUKEMIA (2005)
Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis
K Hartmann et al.
GASTROENTEROLOGY (2005)
PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib
CL Corless et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)
T Nanri et al.
LEUKEMIA (2005)
Gastrointestinal stromal tumors of the stomach - A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential
J Lasota et al.
LABORATORY INVESTIGATION (2004)
Prevalence of KIT expression in human tumors
PT Went et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors
E Wardelmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
PDGFRA activating mutations in gastrointestinal stromal tumors
MC Heinrich et al.
SCIENCE (2003)
Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad
JA Carney et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Share Paper
